PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

hydroxychloroquine Side Effects

The reactions most often reported to the FDA for hydroxychloroquine (also sold as Plaquenil), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

71,900
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2004 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of hydroxychloroquine come from 71,900 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 71,900 reports to the FDA Adverse Event Reporting System (FAERS) for hydroxychloroquine (Plaquenil): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

71,900

Reports Mentioning Death

7,814

10.9% of reports — not proof the medicine caused the death

Hospitalizations

20,530

28.6% of reports

Top Indication

Rheumatoid Arthritis

Most Reported Adverse Reactions

RHEUMATOID ARTHRITIS
12,921
PAIN
10,409
ARTHRALGIA
9,276
FATIGUE
8,853
JOINT SWELLING
8,528
RASH
7,370
CONDITION AGGRAVATED
7,013
SYNOVITIS
6,692
NAUSEA
6,584
CONTRAINDICATED PRODUCT ADMINISTERED
6,430
TREATMENT FAILURE
6,014
ALOPECIA
5,939
HEADACHE
5,900
ABDOMINAL DISCOMFORT
5,881
ARTHROPATHY
5,825
SYSTEMIC LUPUS ERYTHEMATOSUS
5,719
PERIPHERAL SWELLING
5,499

Who Reports Side Effects

Gender Distribution

Female 48,695 (78%)
Male 13,464 (22%)
Unknown 50

Age Distribution

0-17 2,244 (5%)
18-44 13,170 (27%)
45-64 19,883 (41%)
65-74 8,915 (18%)
75+ 4,426 (9%)

Reporting Trend by Year

2004 2025

Reactions in Death Reports

Top reactions reported in 7,814 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
SYSTEMIC LUPUS ERYTHEMATOSUS 1,618
RHEUMATOID ARTHRITIS 1,595
GLOSSODYNIA 1,577
GENERAL PHYSICAL HEALTH DETERIORATION 1,575
JOINT SWELLING 1,571
TYPE 2 DIABETES MELLITUS 1,555
HAND DEFORMITY 1,537
INFUSION RELATED REACTION 1,535
FATIGUE 1,520
FIBROMYALGIA 1,518
PAIN 1,504
HYPERTENSION 1,500
HEPATIC ENZYME INCREASED 1,492
PSORIATIC ARTHROPATHY 1,492
RASH 1,492
DUODENAL ULCER PERFORATION 1,488
SYNOVITIS 1,478
WOUND 1,475
HYPOAESTHESIA 1,472

Reactions in Hospitalization Reports

Top reactions in 20,530 reports where hospitalization was an outcome.

Reaction Reports
RHEUMATOID ARTHRITIS 3,601
PAIN 3,570
FATIGUE 3,397
ARTHRALGIA 3,387
CONDITION AGGRAVATED 3,134
RASH 3,054
JOINT SWELLING 3,006
SYNOVITIS 3,005
ARTHROPATHY 2,919
NAUSEA 2,876
SYSTEMIC LUPUS ERYTHEMATOSUS 2,544
DRUG HYPERSENSITIVITY 2,534
ABDOMINAL DISCOMFORT 2,479
INFUSION RELATED REACTION 2,461
HEADACHE 2,458
VOMITING 2,422
HYPERSENSITIVITY 2,420

Compare hydroxychloroquine vs abatacept →

What the FAERS Data Reveals About hydroxychloroquine Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 71,900 voluntary reports linked to hydroxychloroquine and its brand equivalents (Plaquenil), spanning 2004 through 2025. Of those, 7,814 (10.9%) listed death as an outcome and 20,530 (28.6%) involved hospitalization. The most common indication reported alongside adverse events was Rheumatoid Arthritis.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 78% were female and 22% male; age distribution skews toward 45-64, with 19,883 reports in that bracket. The single most reported reaction is rheumatoid arthritis with 12,921 submissions, followed by pain and arthralgia.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.

Drugs With a Similar FAERS Report Volume

Other medications with a total FDA adverse-event report count closest to hydroxychloroquine's 71,900.